Customer Support: 800-526-4902
 

Dennis Gregory: Lawyer with Fitzpatrick, Cella, Harper & Scinto

Dennis Gregory

LinkedIn
Phone(212) 218-2220

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Litigation
  • Pharmaceuticals & Chemicals
 
University Siena College, B.S., Biology, cum laude, 1996
 
Law SchoolSeton Hall University School of Law, J.D., cum laude, 2003
 
Admitted2004, New York; U.S. Patent and Trademark Office, 2002
 
Memberships Federal Circuit Bar Association; New York Intellectual Property Law Association (Member, Committee on Antitrust, Inequitable Conduct and Misuse); American Intellectual Property Law Association.

 
BornAlbany, New York, May 6, 1974
 
Biography

Professional Experience

Dennis Gregory's practice focuses on pharmaceutical patent litigation. While in law school, Mr. Gregory was a member of the Seton Hall Law Review, elected to the Order of the Coif, and worked as an intern for Hon. Katharine S. Hayden of the United States District Court for the District of New Jersey.

Mr. Gregory has handled matters relating to thrombin inhibitors, beta-blockers, calcium channel blockers, and formulation technologies, as well as freedom to operate issues related to importation of pharmaceuticals into the United States. Mr. Gregory also has appellate experience, including assisting with several amicus curiae briefs to both the Supreme Court and the Court of Appeals for the Federal Circuit.

Professional Activities

New York Intellectual Property Law Association (Committee on Antitrust, Inequitable Conduct & Misuse); American Intellectual Property Law Association; Federal Circuit Bar Association

Representative Cases

Unigene Laboratories, Inc. and Upsher-Smith Laboratories, Inc v. Apotex, Inc.
United States Court of Appeals for the Federal Circuit

In re Rosuvastatin Calcium Patent Litigation
D. Del. 2010

Unigene Labs., Inc., et al. v. Apotex, Inc., et al.
S.D.N.Y., 2009

Publications

Ass'n for Molecular Pathology v. USPTO, No. 2010-1406 (the Myriad Genetics case)
Fitzpatrick Case Update
July 29, 2011

MedImmune: Changing the US Licensing Landscape
Intellectual Asset Management
Summer 2007

Injunctions for patent infringement after the eBay decision
Intellectual Asset Management
February 2007

Extraordinary Remedies in US Patent Litigation
Intellectual Asset Management
February 2006

A Response to Recommendation No. 2 of "To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy", a Report by the Federal Trade Commission
Report of American Intellectual Property Law Association, 2004
April 2004

Events

Developments in Pharmaceutical and Biotech Patent Law 2010
Practicing Law Institute
Partner Colleen Tracy spoke at PLI's Developments in Pharmaceutical and Biotech Patent Law 2010 Conference on September 16, 2010.
September 16, 2010

 
ISLN917744684
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

Ass’n for Molecular Pathology v. USPTO, No. 2010-1406 (July 29, 2011) (the Myriad Genetics case)
Robert H. Fischer,Dennis Gregory, August 12, 2011
The Federal Circuit today issued a key biotechnology opinion, holding that isolated human DNA sequences are patentable subject matter under 35 U.S.C. § 101. Ass’n for Molecular Pathology v. USPTO, No. 2010-1406 (July 29, 2011).
Profile Visibility
#14,327 in weekly profile views out of 90,234 lawyers in New York, New York
#185,926 in weekly profile views out of 1,447,639 total lawyers Overall

Office Information

Dennis Gregory
Fitzpatrick, Cella, Harper & Scinto
1290 Avenue of the Americas
New York, NY 10104-3800




Loading...
 

Video

 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now